Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Journal of Clinical Oncology

• Publication date

  1988-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1988.6.10.1590PMID 3171626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adjuvant chemotherapy of bladder cancer: a preliminary report.

  1988cited by this paper
• M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

  1988cited by this paper
• Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.

  1979cited by this paper
• The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report).

  1976cited by this paper
• A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

  1965cited by this paper

• The impact of squamous cell transformation on the prognosis of patients treated with radical nephroureterectomy

  2024cites this paper
• Prognostic Values and Treatment Responses Evaluated with Lymphovascular Invasion, Perineural Permeation, and Histologic Transformation for Urothelial Cancer

  2024cites this paper
• Neoadjuvant and adjuvant chemotherapy share equivalent efficacy in improving overall survival and cancer-specific survival among muscle invasive bladder cancer patients who undergo radical cystectomy: a retrospective cohort study based on SEER database

  2023cites this paper
• Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma.

  2022cites this paper
• Peri-operative Chemotherapy for Muscle-Invasive Bladder Cancer

  2019cites this paper
• Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy.

  2019cites this paper
• Brazilian consensus in muscle-invasive and metastatic urothelial carcinoma

  2019cites this paper
• Treatment of musculo-invasive bladder cancer with poor prognosis: urgency of the problem

  2018cites this paper
• Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

  2018cites this paper
• Chapter 26 – Adjuvant Chemotherapy

  2018cites this paper
• 5 - Trattamento Chirurgico Della Malattia Muscolo-Invasiva E Localmente Avanzata (MIBC).

  2018cites this paper
• Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017

  2017cites this paper
• Landmarks in the treatment of muscle-invasive bladder cancer

  2017cites this paper
• Systemic Chemotherapy in Muscle Invasive and Metastatic Bladder Cancer: Present and Future

  2017cites this paper
• Chemotherapy for Muscle-Invasive Bladder Cancer

  2016cites this paper
• The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy

  2016cites this paper
• Blasenkarzinom Teil 1: Radikale Zystektomie, neoadjuvante und adjuvante Therapiemodalitäten

  2016cites this paper
• Maligne Tumoren der Harnblase

  2016cites this paper
• Neoadjuvant therapy in muscle-invasive bladder cancer: a model for rational accelerated drug development.

  2015cites this paper
• Towards effective adjuvant treatment for urothelial cancer.

  2015cites this paper
• Significance of lymphovascular invasion in organ‐confined, node‐negative urothelial cancer of the bladder: data from the prospective p53‐MVAC trial

  2015cites this paper
• Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?

  2015cites this paper
• Management of Bladder Cancer, Role of Chemotherapy and Controversies Surrounding Its Application

  2015cites this paper
• Treatment of MIBC - Neoadjuvant Chemotherapy: New Standard of Care

  2015cites this paper
• Urothelial carcinoma with squamous differentiation: response to chemotherapy and radiation.

  2015cites this paper
• Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.

  2015cites this paper
• Management of muscle-invasive bladder cancer in the elderly

  2015cites this paper
• Nestin Is an Independent Predictor of Cancer-Specific Survival after Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder

  2014cites this paper
• Predictors of outcome in bladder cancer.

  2014cites this paper
• Refining patient selection for neoadjuvant chemotherapy before radical cystectomy.

  2014cites this paper
• Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

  2014cites this paper
• Impact of Squamous and Glandular Differentiation on Oncologic Outcomes in Upper and Lower Tract Urothelial Carcinoma

  2014cites this paper
• Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

  2013cites this paper
• Management of bladder cancer: A literature review

  2013cites this paper
• ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.

  2013cites this paper
• Análise dos fatores prognósticos patológicos de pacientes submetidos à cistectomia radical e linfadenectomia por neoplasia urotelial de bexiga

  2013cites this paper
• Nicht-invasive und invasive Urothelneoplasien

  2013cites this paper
• Role of systemic chemotherapy in urothelial urinary bladder cancer.

  2013cites this paper
• The treatment of muscle-invasive bladder cancer in elderly patients

  2013cites this paper
• Recommendations for the optimal management of early and advanced urothelial carcinoma.

  2012cites this paper
• Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer

  2012cites this paper
• Management of Metastatic and Invasive Bladder Cancer

  2012cites this paper
• A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2‐T4aN0‐N2M0 bladder cancer

  2012cites this paper
• Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?

  2011cites this paper
• Principles of Chemotherapy

  2011cites this paper
• Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?

  2011cites this paper
• [The role of chemotherapy in the management of bladder cancer].

  2011cites this paper
• Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited.

  2010cites this paper
• The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder

  2010cites this paper
• Clinical Cancer esearch cer Therapy : Clinical Effectiveness of Off-Protocol Adjuvant Chemotherapy for R ients with Urothelial Carcinoma of the Urinary Bladder

  2010cites this paper
• 23Chemotherapy in Bladder Cancer: A Good Concept But Where's the Proof?

  2010cites this paper
• The role of adjuvant chemotherapy in patients with locally advanced (pT3, pT4a) and/or lymph node–positive bladder cancer

  2010cites this paper
• La integracin de la ciruga y el tratamiento quimioterpico en el cncer de vejiga infiltrante

  2009cites this paper
• Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?

  2009cites this paper
• Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience

  2009cites this paper
• Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.

  2009cites this paper
• The impact of variant histology on the outcome of bladder cancer treated with curative intent.

  2009cites this paper
• Adjuvant Chemotherapy in Bladder Cancer: A Good Concept But Where’s the Proof?

  2009cites this paper
• Comprehensive surgical and chemotherapy treatment for invasive bladder cancer.

  2009cites this paper
• The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer

  2008cites this paper
• [Metastases from urethelial carcinoma: role of chemotherapy].

  2008cites this paper
• Adjuvant chemotherapy for invasive bladder cancer

  2008cites this paper
• Treatment of locally advanced and metastatic bladder cancer

  2008cites this paper
• Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors.

  2007cites this paper
• hemotherapy for Bladder Cancer : reatment Guidelines for Neoadjuvant hemotherapy , Bladder Preservation , djuvant Chemotherapy , and Metastatic ancer

  2007cites this paper
• Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.

  2007cites this paper
• Clinical and therapeutic significance of aberrant differentiation patterns in bladder cancer

  2007cites this paper
• Chemotherapy by M-VAC protocol in progressive bladder carcinoma treatment.

  2007cites this paper
• Neo-adjuvant and adjuvant chemotherapy — true and false

  2007cites this paper
• Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.

  2007cites this paper
• Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

  2007cites this paper
• Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow.

  2007cites this paper
• Systemic chemotherapy for urothelial cancer.

  2006cites this paper
• Combining surgery and chemotherapy for invasive bladder cancer: current and future directions

  2006cites this paper
• Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.

  2006cites this paper
• Perioperative chemotherapy for bladder cancer.

  2006cites this paper
• Adjuvant chemotherapy in muscle‐invasive bladder carcinoma

  2006cites this paper
• Complete long‐term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer

  2006cites this paper
• Adjuvant chemotherapy of bladder cancer.

  2006cites this paper
• The role of perioperative chemotherapy in the treatment of urothelial cancer.

  2006cites this paper
• Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials

  2005cites this paper
• Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.

  2005cites this paper
• The current and future application of adjuvant systemic chemotherapy in patients with bladder cancer following cystectomy.

  2005cites this paper
• Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management

  2005cites this paper
• Pharmakologische Therapie des fortgeschrittenen und metastasierten Urothelkarzinoms

  2005cites this paper
• Systemische Therapie des fortgeschrittenen Urothelkarzinoms

  2005cites this paper
• Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy

  2005cites this paper
• Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?

  2005cites this paper
• Lymphovascular Invasion Is Independently Associated With Overall Survival, Cause-Specific Survival, and Local and Distant Recurrence in Patients With Negative Lymph Nodes at Radical Cystectomy

  2005cites this paper
• Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.

  2005cites this paper
• Nodal Involvement in Bladder Cancer

  2004cites this paper
• Adjuvant chemotherapy following radical cystectomy

  2004cites this paper
• Long-term Outcome of Adjuvant Chemotherapy with MVP-CAB Regimen (Methotrexate, Vincristine, Cisplatin, Cyclophosphamide, Adriamycin and Bleomycin) for Locally Advanced Bladder Cancer

  2004cites this paper
• Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: a study by the Hellenic Cooperative Oncology Group.

  2004cites this paper
• Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer

  2004cites this paper
• Neoadjuvant chemotherapy for bladder cancer.

  2003cites this paper
• Seminar article Neoadjuvant chemotherapy for bladder cancer

  2003cites this paper
• Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy.

  2003cites this paper
• Systemische Chemotherapie des Urothelkarzinoms

  2003cites this paper
• [Systemic chemotherapy for transitional cell carcinoma of the urothelium].

  2003cites this paper